The objective of the present study was to determine the relationship between concentrations of antibodies in serum and those in gingival crevicular fluid (GCF) of patients with juvenile periodontitis and severe periodontitis. Most antigens used to quantitate antibodies were obtained from a panel of bacteria associated with juvenile periodontitis or severe periodonititis. We further investigated variation in antibody titer among different periodontal sites and the extent to which antibody in GCF is locally derived. Titers of antibody, total immunoglobulin G (IgG), and human serum albumin were determined with sensitive radioimmunoassays. The relationship between serum and GCF antibody was complex. Both person-to-person variability and marked variability within the same subject were found among different sites of similar clinical status. The site-to-site variability was found not only for ailtibody reactive with periodontal organisms, but also for antitetanus toxoid, total IgG, and even human serum albumin. Generally the variability was in the degree of depression of the level in GCF relative to that in serum. However, anti-Bacteroides gingivalis and anti-Actinobacillus actinomycetemcomitans in GCF often exceeded the level in serum. When antibody titers in serum and GCF were calculated per milligram of human serum albumin, most of the apparent depressions of antibody in GCF disappeared. The ratio of antibody in serum to that in GCF approached unity for all organisms except B. gingivalis and A. actinomycetemcomitans Y4, which were markedly elevated. Furthermore, the level of IgG per milligram of human serum albumin in GCF was about twice the level in serum. We believe that human serum albumin reflects serum contribution to the GCF, and we therefore attribute the increased level of IgG per milligram of albumin in GCF to local synthesis. It appears that anti-B. gingivalis and anti-A. actinomycetemcomitans represent an important portion of this local antibody synthesis, since most seropositive patients with severe or juvenile periodontitis had at least one site elevated, and the magnitudes of the elevations were large in many sites. Those sites yielding elevated antibody exhibited no obvious differences in clinical parameters of probeable depth or attachment level as compared with sites in which antibody levels in GCF were similar to serum levels. Elevated antibody in GCF may relate to changes in disease activity that are not detectable by usual clinical measures.
In a recent study we found that, compared with young adults with a healthy periodontium, young adults with generalized severe periodontitis (SP) or localized periodontitis (JP) were frequently seropositive to Bacteroides gingivalis, Actinobacillus actinomycetemcomitans, Peptostreptococcus micros, Fusobacterium nucleatum, Eubacterium brachy, and Eubacterium timidum. Antibody titers were often found to Eubacterium nodatum and Bacteroides intermedius (genospecies 4197 and 8944), but no significant differences between this with a healthy periodontium and JP or SP were found (31) . All of these species are found in subgingival flora or SP and JP subjects and are potential periodontal pathogens (21, 22) . These results are consistent with other reports that periodontitis patients are frequently seropositive for certain microorganisms in their gingival plaque (1, 6-11, 16, 18, 20, 22-26, 30, 33) . Antibodies reactive with periodontitis-associated organisms have also been found in gingival crevicular fluid (GCF). The levels of antibodies in GCF were reported to vary from site to site in the same person. Furthermore, levels of antibody in some sites exceeded levels in serum, supporting the concept of local antibody synthesis in gingival tissues (7) . In one reported case the sites showing elevated antibody production were shown to correlate with subsequent periodontal destruction (12) . * Corresponding author.
The present study was undertaken to determine the relationship in JP and SP patients between antibody in GCF reactive with a panel of JP-or SP-associated bacteria and the same antibody reactivities in serum. We further investigated site-to-site variation and the extent to which antibody in GCF to periodontitis-associated organisms is locally derived. Relative to serum, titers of antibody to most organisms were depressed in the GCF. However, these depressions disappeared when the data were standardized by calculating titers as per milligram of human serum albumin (HSA). Titers of antibody reactive with B. gingivalis and A. actinomycetemcomitans were often markedly elevated compared with serum titers. In addition, much of the immunoglobulin G (IgG) in the GCF of JP and SP patients was locally produced, and in many sites a large proportion of this locally produced antibody was reactive with B. gingivalis or A. actinomycetemcomitans or both.
MATERIALS AND METHODS
Human subjects and samples. The subjects of study had experienced advanced periodontal disease before age 30. They were diagnosed as fitting either the clinical patterh of localized JP or generalized SP as previously described (4) . In brief, JP subjects had experienced advanced loss of attachment, pocket formation, and bone loss essentially limited to first molar and incisors, whereas in the SP subjects the advanced periodontal destruction had involved eight or more teeth, at least three of which were not first molars Radioimmunoassay. Details of the solid-phase radioimmunoassay technique used for detection and quantitation of specific antibody have been described elsewhere (31 The radioimmunoassay for total IgG has been described previously (5) . HSA was assayed by using the same method. Control for quantitative elution of test materials from the paper strips was obtained by assaying IgG and HSA after placement on the strips and elution as compared with direct dilution of the same quantities in eluent. Significant differences were not found. Assays with various concentrations of newborn calf serum in the diluent established that, between 10 and 50% newborn calf serum, background counts diminish, but the difference between total and background counts remains the same. We therefore used 50% newborn calf serum as a convenience for minimizing background counts without affecting the magnitude of the data unit used for analysis.
Antibody analysis. Initially the titer in serum of antibody reactive with each of the 12 bacterial strains and for tetanus toxoid was established. Once serum titers were known, the strains to be used for assaying antibody in GCF were determined. Since available volumes of GCF were small (generally 0.2 to 5 ,ul per site) assays were performed with only those bacterial preparations for which a high serum titer had been found. A second serum assay was also performed when GCF assays were done, so that the serum and GCF titers determined under identical conditions could be compared. When the antibody level in GCF was as high or higher than that in serum, a GCF titer was easily determined as described above. However, when the antibody level in GCF was substantially lower than that in serum, it was not possible to establish the titer with confidence because the delta cpm at the lowest GCF dilution did not reach the endpoint. We could only estimate how much lower the GCF titer was than the serum titer by comparing GCF and serum curves below the endpoint. Consequently, some depressed GCF data points are listed as estimates. However, serum curves and GCF curves from the same person tended to be similar with respect to slope and maximum counts bound. The GCF curves at various sites appeared simply to be shifted up or down on the dilution scale from the serum curve. Thus, the estimates are quite accurate.
As an indication of specificity of the antibodies detected, inhibition experiments were conducted with each antigen preparation and respective known positive sera. Assay strips were coated with a given sonicate. Sera were incubated with the homologous or each heterologous sonicate before addition to the assay wells. Results were compared with those where serum with no added sonicate was used, to yield percent inhibition. Homologous sonicates inhibited binding nearly 100% in each instance, but in no case did A. actinomycetemcomitans or B. gingivalis inhibit the reciprocal reactivity, nor was their any reciprocal inhibition between either of those and any other of the specis used in this study.
RESULTS
High serum titers against B. gingivalis, A. actinomycetemcomitans Y4, P. micros, B. intermedius 8944, and tetanus toxoid were frequently found. Such results are illustrated in Table 2 by data from two SP (no. 580 and 503) and two JP (no. 502 and 488) subjects. Subject 580 had high titers in serum against B. gingivalis, P. micros, and B. intermedius 8944. Titers in serum against the other organisms were too low to test. Data from three GCF sites are illustrated for this subject. Site 12D appears to have suffered the least previous periodontal damage, with only 3-mm probeable depth and an attachment level 1 mm apical to the cemento-enamel junction. However, 93,000 U of antibody reactive with B. gingivalis per ml were found in GCF from this site, as compared with 45,000 U/ml in serum. In contrast, the titer to B. gingivalis at site 13M, which exhibited greater probeable depth and a more apical attachment level, was about the same titer as that in serum. In further contrast, antibody in GCF from site 15M, which also had more advanced periodontitis than did 12D, is markedly lower than that in serum. In spite of the elevated anti-B. gingivalis titer at site 12D, the antibody titers against P. micros and B. intermedius 8944 in this site were depressed relative to those in serum. Furthermore, the levels of total IgG and HSA were lower than in serum (The E following many of the data points for depressed antibody levels indicates that these numbers were estimates.)
The other three patients' data recorded in Table 2 have similar patterns. GCF from some gingival sites had relatively elevated antibody titers, but generally were relatively depressed, as were the levels of total IgG and HSA, although the degree of depression varied from site to site. No consistent relationship was observed between the quantity or flow rate of GCF collected and antibody, IgG, or HSA concentration.
In the overall data, anti-B. gingivalis, anti-A. actinomycetemcomitans, and an occasional total IgG titer provided the only elevated GCF titers relative to serum (Fig. 1) A. actinomycetemcomitans Y4 GCF/serum ratios were substantially increased over that for anti-tetanus toxoid. This is consistent with the concept of a local specific antibody response, in particular local synthesis of antibodies to B. gingivalis and A. actinomycetemcomitans Y4. The sites that were elevated for anti-B. gingivalis or anti-A. actinomycetemcomitans tended to be the same sites that were high for total IgG. For example the highest GCF/serum ratio for specific antibody was just over 8 for anti-A. actinomycetemcomitans Y4. This is the same site that exhibited a ratio of over 2 for total IgG. To see whether the tendency for certain sites to have high IgG titers correlated with elevated anti-B. gingivalis and anti-A. actinomycetemcomitans, we compared the IgG and HSA titers in sites that were specifically elevated for those antibodies. As indicated in Table 3 , where only antibodies to B. gingivalis or A. actinomycetemcomitans are included, the mean GCF/serum ratio of IgG levels at sites elevated for those antibodies exceeded that ratio at sites where those antibody levels were lower in GCF than in serum. In fact, the depressed sites approached the GCF/serum ratio of IgG concentration found for antibodies to P. micros, B. intermedius, and tetanus toxoid. In contrast, mean ratios of GCF/serum HSA levels were not significantly different between sites with elevated antibody ratios and those with depressed ratios. HSA appeared to be a common denominatoK\.between sites with elevated and depressed antibody ratios. Accordingly, we normalized the data by using HSA as the standard. When results were expressed as units of antibody per milligram of HSA, much of the site-to-site variability disappeared. Furthermore, when the units of antibody per milligram of HSA in GCF was divided by the units of antibody per milligram of HSA in serum, the quotient for most organisms approached 1. The exceptions (Table 4) were for anti-B. gingivalis, and anti-A. actinomycetemcomitans Y4, and total IgG. All other antibody ratios were statistically insignificantly different from unity.
To provide an indication of how often persons had sites with elevated antibody ratios, the frequency of persons with at least one such site is indicated in Table 5 . The average number of sites sampled per person was 3.4. However, the number of sites ranged from one to nine, so the probability of finding an elevated site differed from person to person. Nevertheless, of eight persons with a serum anti-B. gingivalis titer adequate to test with GCF, six had at least one site with a titer that exceeded that in serum. Three of these people had sites with titers in excess of 2.5 times the serum level. Similarly, two of five people with a high serum anti-A. actinomycetemcomitans Y4 titer had at least one site The number of GCF samples with elevated antibody to either B. gingivalis or A. actinomycetemcomitans and those with depressed antibody levels were compared among sites which had an attachment level more than, versus less than, 2 mm apical to the cemento-enamel junction, by using 2 x 2 chi-square analysis. No significant difference was found (P > 0.05).
DISCUSSION
The results reported here indicate considerable site-to-site variability in the composition of GCF in patients with JP and SP. The levels of HSA in GCF from different sites were variable, but consistently lower than those in serum. Similarly, the levels of IgG in GCF were generally lower than those in serum, but occasionally levels as high or even higher than those in serum were encountered. In agreement with Ebersole et al. (7) , antibody in GCF reactive with the periodontitis-associated bacteria tested also showed marked site-to-site variability, but titers against most strains were lower than those in serum. The same pattern of variable, but depressed, antibody titers was found against tetanus toxoid, a nonoral antigen.
Variability in the levels of IgG in GCF is consistent with the findings of Shillitoe and Lehner (29) , who reported IgG levels that varied from near serum levels to a small fraction of that found in serum in a diverse group of periodontal patients. However, others have reported that IgG is present in similar concentrations in serum and GCF (3, 14, 32) or only moderately diluted in GCF compared with serum (28). The reasons for this discrepancy are not clear. However, generally the plasma protein content of transudates is only a fraction of the normal serum concentration (2) . A textbook description of inflammatory lesions indicates the following. "There is some correlation in man between the severity of injury and the composition of the inflammatory exudate. Mild injuries produce a protein-poor watery transudate. With progressively more powerful stimuli, the exudate acquires higher and higher concentrations of plasma proteins (a process described as molecular sieving). Red cells appear only in the most severe forms of injury which cause necrosis of small vessels" (27) . With the suction blister technique, the plasma protein content of interstitial fluid has been studied, and an inverse relationship between protein size and interstitial fluid concentration was obtained (34) . The ratio of plasma proteins in suction blister fluid to plasma varied from 0.9 for insulin to 0.14 for alpha 2-macroglobulin. The blister fluid/serum albumin ratio was 0.29, and the ratio for molecules the size of IgG was about 0.2 (34) . When plasma is diluted with interstitial fluid at sites of gingival inflammation, one would expect variability in protein content in GCF, depending upon the extent of local vessel damage. The content of albumin and IgG in our GCF varied from plasma concentrations to interstitial fluid concentrations and is consistent with GCF representing a mixture of the two fluids. If differences in the mixture are the explanation for the observed variability, one measure of severity of vessel damage in a gingival lesion would be the content of albumin in the GCF. A high level of albumin would indicate damage to the molecular sieve, leakage of serum proteins, and a more damaged site. Elevations in IgG may be more difficult to interpret, because it appears that variable quantities of IgG are synthesized locally and released in GCF.
In contrast to the general results for antibody reactive with other species, antibody reactive with B. gingivalis or A. actinomycetemcomitans was often markedly elevated in GCF in comparison with serum. These antibodies in GCF showed remarkable site-to-site variability. The average site had more antibody than did serum, whereas the average site with respect to antibody to other species and to tetanus toxoid had much less. This tendency for anti-B. gingivalis and anti-A. actinomycetemcomitans in GCF to exceed serum levels was emphasized when the data were standardized to the content of HSA. Per milligram of HSA, serum and GCF contained comparable amounts of antibody against tetanus toxoid and most oral species tested, but contained markedly higher levels of anti-B. gingivalis and anti-A. actinomycetemcomitans. We believe that these results indicate that a local antibody response in contributing to the concentration of antibody against B. gingivalis and A. actinomycetemcomitans in GCF. This is consistent with the results reported by others (7, 19, 24) . Local antibody may be on October 19, 2017 by guest http://iai.asm.org/ Downloaded from synthesized against tetanus toxoid and bacteria via polyclonal activation, but the marked elevation in anti-B.
gingivalis and A. actinomycetemcomitans titers over serum in certain sites is difficult to explain by polyclonal activation alone. However, it is conceivable that, after or together with antigen-specific stimulation, the levels of antibody produced could be enhanced by polyclonal stimulation.
The significance of such a potent local antibody response to B. gingivalis and A. actinomycetemcomitans is not clear, but may relate to a basic pathogenic mechanism such as the ability to invade the gingival lesion. The selectivity of the local response for these organisms is consistent with the hypothesis that these two bacteria are important pathogens in early onset periodontitis. This is also supported by the case report that indicated that most elevated sites for anti-A. actinomycetemcomitans suffered periodontal damage after the detection of the local antibody response (12) . The question of how unique these two organisms are in their ability to induce such potent local antibody responses in JP and SP subjects remains open. However, the fact that elevated IgG titers correlate so well with sites exhibiting elevated GCF antibody to these two species suggests that there are not many other species as significantly involved. Certainly, elevations of antibody to P. micros, B.
intermedius 8944, and B. intermedius 4197 in GCF were rare, even though these organisms make up a substantial portion of the subgingival flora in SP and JP patients (21, 22) . Further study is indicated to determine whether enhanced local production of antibody, detectable in GCF, is related to active disease progression.
